Physician profile
James D Frederick
NPI 1881798502
$1,095.90
in general payments reported to CMS, 2019-2025
18 companies · $63.41 in 2025
The $63.41 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $244 · 2021: $215 · 2022: $378 · 2023: $86.29 · 2025: $63.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $300.97 | 2019-2022 | |
| Novo Nordisk INC | $108.76 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $101.64 | 2021-2025 | |
| Lilly USA, LLC | $97.63 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $76.63 | 2020-2021 | |
| Pfizer INC. | $73.64 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $69.46 | 2021-2023 | |
| Supernus Pharmaceuticals, INC. | $55.28 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.07 | 2019-2021 | |
| Abbott Laboratories | $37.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.31 | 2021 | |
| Mylan Specialty L.P. | $16.69 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.28 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.74 | 2025 | Caplyta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $12.57 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.71 | 2020 | |
| Allergan, INC. | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.